Georgetown University clinical trial pipeline

9 trials changed in the last 30 days: 1 stopped, 4 with notable changes, 4 with minor changes only.

1. Stopped

   Combination Therapy Strategy to Prevent Anti-PD-1 Therapy…Combination Therapy Strategy to Prevent Anti-PD-1 Therapy Resistance in Metastatic Ovarian Cancer Patients

   Withdrawn before enrolling

   Sponsor's reason: Sponsor Decision

   Georgetown University·Phase 2· NCT05479045· Registry history of NCT05479045 on ClinicalTrials.gov (opens the registry)

   Updated Oct 9, 2026

2. Notable

   Patient and Provider Intervention to Address Health Disparities in…Patient and Provider Intervention to Address Health Disparities in Lung Cancer Screening

   Primary completion pushed from Dec 31, 2025 to Dec 31, 2026

   Also in this update: Enrollment closed, study ongoing; Completion pushed from Feb 28, 2026 to Feb 28, 2027

   Georgetown University·Not applicable· NCT04675476· Registry history of NCT04675476 on ClinicalTrials.gov (opens the registry)

   Updated Oct 7, 2026

3. Notable

   Gemcitabine, Cisplatin and Nab-Paclitaxel as Neoadjuvant Treatment…Gemcitabine, Cisplatin and Nab-Paclitaxel as Neoadjuvant Treatment · Resectable or Borderline Resectable Pancreatic Cancer

   Primary completion pushed from Dec 31, 2026 to Aug 31, 2027

   Also in this update: Sponsor changed: Emory University to Georgetown University

   Georgetown University·Phase 2· NCT06423326· Registry history of NCT06423326 on ClinicalTrials.gov (opens the registry)

   Updated Sep 30, 2026

4. Notable

   TLC · Older Breast Cancer Patients: Risk for Cognitive Decline

   Primary and study completion pushed from Apr 30, 2025 to Apr 30, 2027

   Georgetown University·Not specified· NCT03451383· Registry history of NCT03451383 on ClinicalTrials.gov (opens the registry)

   Updated Sep 28, 2026

5. Notable

   RESET · RESvEraTrol in Parkinson's Disease (RESET)

   Recruitment opened

   Georgetown University·Phase 2· NCT07592767· Registry history of NCT07592767 on ClinicalTrials.gov (opens the registry)

   Updated Sep 18, 2026

• Stopped: an ongoing trial was terminated, suspended or withdrawn.
• Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
• Minor: routine progress and housekeeping, such as sites added or enrollment closed.